Concourse Financial Group Securities, Inc. Mainz Biomed N.V. Call Options Transaction History
Concourse Financial Group Securities, Inc.
- $1.64 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding MYNZ
# of Institutions
12Shares Held
191KCall Options Held
0Put Options Held
0-
Vontobel Holding Ltd.45KShares$10,8000.0% of portfolio
-
Northern Trust Corp Chicago, IL29.9KShares$7,1840.0% of portfolio
-
Steward Partners Investment Advisory, LLC29KShares$6,9600.0% of portfolio
-
Two Sigma Securities, LLC New York, NY23.5KShares$5,6430.0% of portfolio
-
Geode Capital Management, LLC Boston, MA15.2KShares$3,6450.0% of portfolio
About MAINZ BIOMED N.V.
- Ticker MYNZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 14,483,000
- Market Cap $3.48M
- Description
- Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a product candidate for a pancreatic cancer screening test; GenoStrip to detect pathogens in environments...